Investigation of Angiotensin-Converting Enzyme Inhibitory Effects of Indonesian Traditional Medicine (Jamu)

Aprilita Rina Yanti Eff*, Hermanus Ehe Hurit, Sri Teguh Rahayu, Ayu Puspita Lena

Department of Pharmacy Faculty of Health Sciences, Esa Unggul University, Jakarta, Indonesia
Corresponding Author:; Tel: +628129939727
Recieved Date: 15 February 2021; Accepted Date: 07 April 2021; Published Date: 03 May
Citation: Eff ARY, Hurit HE, Rahayu ST, Lena AP. Investigation of Angiotensin-Converting Enzyme Inhibitory Effects of Indonesian Traditional Medicine (Jamu). Trop J Nat Prod Res. 2021; 5(4): 692-697.
© 2021 Eff et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


The renin-angiotensin-aldosterone system (RAAS) is a significant factor in maintaining blood pressure. Several Indonesian plants in herbal medicine (jamu) have been proven in vitro to be ACE inhibitors. This study assessed the angiotensin-converting enzyme inhibitory effects of antihypertensive jamu in Wistar rats.  Thirty rats were divided into six groups. Group I represented the standard controls (SC), which was administered standard diet, and aqua dest drinks. Groups II to VI were made hypertensive by administering 10% fructose drink for ten weeks. Group II was the negative control (NC), and was administered standard diet and 10% fructose solution. Captopril (0.5 mg/kg BW) was administered to group III, while groups IV – VI were administered jamu at doses of 120 mg/kg BW (D1), 240 mg/kg BW (D2), and 360 mg/kg BW (D3), respectively from day 57 to 71. Blood pressure was measured every week before giving fructose until the last day of treatment. On day 72, rats were sacrificed, and plasma was taken to measure angiotensin-converting enzyme activity using an ELISA reader.  In the groups: Captopril, D1, D2, and D3, there was a significant decrease in systolic and diastolic blood pressure compared to the negative control (p < 0.05). Plasma angiotensin-converting enzyme levels were significantly different between the negative control and the normal control, D1, D2, D3, and the captopril groups (p < 0.05). There was no significant difference between D3 compared to the standard controls (p > 0.05). Antihypertensive jamu has angiotensin-converting enzyme inhibitory activity.

Keywords: Antihypertensive, Blood pressure, ACE inhibitor, Jamu 
Back to Articles

ISSN: 2616-0684 (Print)
ISSN: 2616-0692 (Online)
DOI: 10.26538/tjnpr
Index Copernicus Value (ICV) for 2017: 59.83
Scopus citescore 0.3 (2020)

Indexing & Abstracting

citescore 0.3 (2020)

j-gate logo

International Innovative Journal Impact Factor

African Index Medicus


Index Copernicus International

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Crossref Content Registration logo

WorldCat Discovery Service

Geneva Foundation for Medical Education and Research